Vlaardingen, Netherlands

Petronella Anna Kreijveld


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Petronella Anna Kreijveld: Innovator in Immune Modulation

Introduction

Petronella Anna Kreijveld is a notable inventor based in Vlaardingen, Netherlands. She has made significant contributions to the field of polysaccharides, particularly in their application for modulating immune responses. With a total of 3 patents to her name, Kreijveld's work is paving the way for advancements in both edible products and pharmaceutical compositions.

Latest Patents

One of her latest patents focuses on polysaccharides that are suitable for modulating immune response. The objective of this invention is to provide polysaccharides that can be used as ingredients in edible products or pharmaceutical compositions. The polysaccharides are derived from specific species and feature a rhamnogalacturonan-I core. Notably, the molar ratio of galacturonyl acid residues to rhamnosyl residues in the backbone of the polysaccharide is close to 1:1. This innovation aims to enhance the immune response through the incorporation of these polysaccharides into various products.

Career Highlights

Kreijveld is currently associated with Nutrileads B.V., where she continues to explore the potential of polysaccharides in health-related applications. Her research and inventions are instrumental in developing new solutions that can benefit both the food and pharmaceutical industries.

Collaborations

Some of her notable coworkers include Ruud Albers and Jari Helin, who contribute to her innovative projects and research endeavors.

Conclusion

Petronella Anna Kreijveld is a pioneering inventor whose work in polysaccharides is making a significant impact on immune modulation. Her contributions are essential for the development of new edible and pharmaceutical products that can enhance health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…